Major response to sunitinib (Sutene®) in metastatic malignant phyllodes tumor of breast

Investigational New Drugs

Volumn 27, Issue 4, 2009, Pages 387-388

  Park, In Hae ^a   Kwon, Youngmee ^a   Kim, Eun A ^a   Lee, Keun Seok ^a   Ro, Jungsil ^a  

^a National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; STEM CELL FACTOR; SUNITINIB; SUTENE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYSTOSARCOMA PHYLLOIDES; DRUG MECHANISM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MASTECTOMY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INDOLES; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PHYLLODES TUMOR; PYRROLES; TREATMENT OUTCOME;

EID: 67651174634     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10637-008-9195-3     Document Type: Article

References (7)

1. MD Rowell RR Perry JG Hsiu 1993 Phyllodes tumors Am J Surg 165 376 379. doi:10.1016/S0002-9610(05)80849-9
2. M Reinfuss J Mitus K Duda 1996 The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases Cancer 77 910 916. doi:10.1002/(SICI)1097-0142(19960301)77:53.0.CO;2-6 (Pubitemid 26061285)
3. GM Tse TC Putti PC Lui 2004 Increased c-kit (CD117) expression in malignant mammary phyllodes tumors Mod Pathol 17 827 831. doi:10.1038/modpathol. 3800125
4. GM Tse PC Lui RA Scolyer 2003 Tumour angiogenesis and p53 protein expression in mammary phyllodes tumors Mod Pathol 16 1007 1013. doi:10.1097/01.MP.0000089907.67419.42
5. DB Mendel AD Laird X Xin 2003 In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship Clin Cancer Res 9 327 337 (Pubitemid 36109749)
6. S Patyna AD Laird DB Mendel 2006 SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity Mol Cancer Ther 5 1774 1782. doi:10.1158/1535-7163.MCT-05-0333
7. LQ Chow SG Eckhardt 2007 Sunitinib: from rational design to clinical efficacy J Clin Oncol 25 884 896. doi:10.1200/JCO.2006.06.3602